These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 14609215

  • 1. Type 1 T regulatory cells and their relationship with CD4+CD25+ T regulatory cells.
    Roncarolo MG, Gregori S, Levings M.
    Novartis Found Symp; 2003; 252():115-27; discussion 127-31, 203-10. PubMed ID: 14609215
    [Abstract] [Full Text] [Related]

  • 2. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
    Pyzik M, Piccirillo CA.
    J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
    [Abstract] [Full Text] [Related]

  • 3. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
    Ahn JS, Krishnadas DK, Agrawal B.
    Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
    [Abstract] [Full Text] [Related]

  • 4. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
    Kuhn A, Beissert S, Krammer PH.
    Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
    [Abstract] [Full Text] [Related]

  • 5. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
    Chen W, Jin W, Hardegen N, Lei KJ, Li L, Marinos N, McGrady G, Wahl SM.
    J Exp Med; 2003 Dec 15; 198(12):1875-86. PubMed ID: 14676299
    [Abstract] [Full Text] [Related]

  • 6. Allogeneic stimulation of naturally occurring CD4+CD25+ T cells induces strong regulatory capacity with increased donor-reactivity.
    Coenen JJ, Koenen HJ, Emmer PM, van Rijssen E, Hilbrands LB, Joosten I.
    Transpl Immunol; 2007 Jun 15; 17(4):237-42. PubMed ID: 17493525
    [Abstract] [Full Text] [Related]

  • 7. CD4+CD25+ regulatory T cells in human hematopoietic cell transplantation.
    Zorn E.
    Semin Cancer Biol; 2006 Apr 15; 16(2):150-9. PubMed ID: 16431128
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Activated CD4+ CD25+ T cells suppress antigen-specific CD4+ and CD8+ T cells but induce a suppressive phenotype only in CD4+ T cells.
    Dieckmann D, Plöttner H, Dotterweich S, Schuler G.
    Immunology; 2005 Jul 15; 115(3):305-14. PubMed ID: 15946248
    [Abstract] [Full Text] [Related]

  • 10. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
    Kullberg MC, Hay V, Cheever AW, Mamura M, Sher A, Letterio JJ, Shevach EM, Piccirillo CA.
    Eur J Immunol; 2005 Oct 15; 35(10):2886-95. PubMed ID: 16180248
    [Abstract] [Full Text] [Related]

  • 11. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.
    Ghiringhelli F, Ménard C, Terme M, Flament C, Taieb J, Chaput N, Puig PE, Novault S, Escudier B, Vivier E, Lecesne A, Robert C, Blay JY, Bernard J, Caillat-Zucman S, Freitas A, Tursz T, Wagner-Ballon O, Capron C, Vainchencker W, Martin F, Zitvogel L.
    J Exp Med; 2005 Oct 17; 202(8):1075-85. PubMed ID: 16230475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
    Karakhanova S, Munder M, Schneider M, Bonyhadi M, Ho AD, Goerner M.
    J Immunother; 2006 Oct 17; 29(3):336-49. PubMed ID: 16699377
    [Abstract] [Full Text] [Related]

  • 14. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.
    Diabetes; 2008 Jan 17; 57(1):113-23. PubMed ID: 17928397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease.
    Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S.
    Semin Immunol; 2004 Apr 17; 16(2):135-43. PubMed ID: 15036237
    [Abstract] [Full Text] [Related]

  • 18. Type 1 T-regulatory cells: their role in the control of immune responses.
    Groux H.
    Transplantation; 2003 May 15; 75(9 Suppl):8S-12S. PubMed ID: 12819483
    [Abstract] [Full Text] [Related]

  • 19. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells.
    Levings MK, Bacchetta R, Schulz U, Roncarolo MG.
    Int Arch Allergy Immunol; 2002 Dec 15; 129(4):263-76. PubMed ID: 12483031
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.